What is N-Acetyl Semax Amidate?

N-Acetyl Semax Amidate 10mg is a synthetic peptide derived from a short sequence of adrenocorticotropic hormone (ACTH) , comprising amino acids 4–10. Originally developed in Russia, this compound has been studied for its neuroprotective, neurotrophic, and neuromodulatory properties . In research, Semax and its acetylated variants are being evaluated for their ability to support cognitive function , improve memory , and promote neuronal recovery in models of ischemic stroke , dementia , and optic nerve inflammation . Antidepressant– and anxiolytic- type effects have also been reported , with a possible contribution to the regulation of serotonin and dopamine levels in the central nervous system.

Mechanism of action and biochemical role

N-Acetyl Semax Amidate 10mg, Semax acts as an ACTH analogue, but without its peripheral hormonal properties, instead focusing its action on the central nervous system . In experimental models, it promotes the gene transcription of neurotrophic factors such as BDNF (Brain-Derived Neurotrophic Factor) and NGF (Nerve Growth Factor) , key molecules for neurogenesis , synaptogenesis , and neuronal plasticity . The increase in BDNF observed after administration of N-Acetyl Semax suggests an improvement in the brain’s ability to adapt to stimuli and lesions, promoting learning, memory, and motor recovery.

In parallel, the peptide exhibits a regulatory effect on neuronal redox balance and mitochondrial stability, crucial elements for cell survival during oxidative or ischemic stress. The overall result is an action profile that combines neuroprotection , gene modulation , and metabolic support for nervous tissue.

Cognitive effects and brain network activity

N-Acetyl Semax Amidate 10mg, Functional magnetic resonance imaging (fMRI) studies have shown that N-Acetyl Semax increases activity in the default mode network (DMN) , a set of brain areas that are more active during resting states than during targeted cognitive tasks. This network is involved in environmental awareness , social attention , and internal reflection . Increased connectivity suggests that the peptide improves basic attention and cognitive alertness, allowing for a more rapid transition from a state of rest to a state of concentration.

Enhanced communication between brain regions—particularly between the prefrontal cortex and the hippocampus—is associated with improved problem-solving , memory , and creativity . Although these observations stem from preclinical studies, they paint a picture consistent with strengthened neural connectivity and overall improved cognitive performance.

Role in neuroprotection and stroke research

N-Acetyl Semax has been used in Russia for research in the context of acute cerebral hypoxia , such as in cases of ischemic stroke or traumatic brain injury . In animal models, the peptide induces changes in the expression of numerous genes involved in cerebral vascular function and the formation of new blood vessels . These changes include the regulation of smooth muscle cell migration, erythropoiesis, and vasculogenesis, promoting improved oxygenation and nutrition of damaged nervous tissue.

In Russian clinical studies, Semax administration during post-stroke rehabilitation was associated with faster motor recovery and higher plasma BDNF levels , suggesting a potential contribution to neuroplasticity and functional reorganization of the brain. These observations support the hypothesis that Semax-induced increases in NAD⁺ and BDNF may facilitate the reconstruction of neuronal connections and improve neuromotor coordination.

Gene expression and neurotrophic factors

Research conducted on healthy animal models has shown that even a single intranasal administration of N-Acetyl Semax produces rapid effects on gene expression in the frontal cortex and hippocampus . These two areas are crucial for attention and cognitive organization , and for memory and learning processes , respectively . The transcriptional activity observed within 20 minutes of treatment includes the activation of the genes for NGF and BDNF , with a direct impact on neuroplasticity and synaptic efficiency.

These results strengthen the idea that N-Acetyl Semax can be used as an experimental model to better understand the molecular mechanisms of learning and memory, paving the way for research strategies to improve cognitive function and brain resilience.

N-Acetyl Semax and mood regulation

Studies indicate that the increase in BDNF produced by Semax can modulate mood and the response to stress. In mouse models of depression , the peptide has been shown to normalize the function of the serotonergic and dopaminergic pathways, suggesting an effect similar or complementary to that of SSRI antidepressants . Unlike the latter, which require weeks to show an effect, Semax’s action on neurotrophic factors is more rapid and direct, stimulating neurogenesis and neuronal plasticity in a short time.

According to some hypotheses, the combination of BDNF stimulators such as Semax and traditional serotonergic therapies could enhance the efficacy of antidepressant treatment, reducing response times and improving neuronal resilience in affective disorders. However, these effects remain limited to experimental and preclinical settings.

Experimental applications and safety

In animal models, N-Acetyl Semax exhibits good subcutaneous bioavailability and a favorable safety profile , with minimal side effects. However, dose conversion from mouse models to humans is not straightforward, and no clinical application is approved. All ongoing research focuses on laboratory uses to further explore the connections between neuroprotection, post-ischemic recovery, and cognitive function . The product is intended for scientific research only and is not approved for human or veterinary use.